Literature DB >> 18236715

Clinical application of EGFR inhibitors in head and neck squamous cell cancer.

Igor Astsaturov1, Roger B Cohen, Paul M Harari.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18236715

Source DB:  PubMed          Journal:  Cancer Treat Res        ISSN： 0927-3042


× No keyword cloud information.
  3 in total

1.  A cell-targeted photodynamic nanomedicine strategy for head and neck cancers.

Authors:  Alyssa Master; Anthony Malamas; Rachna Solanki; Dana M Clausen; Julie L Eiseman; Anirban Sen Gupta
Journal:  Mol Pharm       Date:  2013-04-24       Impact factor: 4.939

Review 2.  EGF receptor-targeted nanocarriers for enhanced cancer treatment.

Authors:  Alyssa M Master; Anirban Sen Gupta
Journal:  Nanomedicine (Lond)       Date:  2012-12       Impact factor: 5.307

3.  Quantitative chemical proteomics reveals new potential drug targets in head and neck cancer.

Authors:  Zhixiang Wu; Jessica B Doondeea; Amin Moghaddas Gholami; Melanie C Janning; Simone Lemeer; Karl Kramer; Suzanne A Eccles; Susanne M Gollin; Reidar Grenman; Axel Walch; Stephan M Feller; Bernhard Kuster
Journal:  Mol Cell Proteomics       Date:  2011-09-28       Impact factor: 5.911
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.